The Situation: Traditional means of transferring a drug product from development to manufacturing along with the requisite information, involves significant formal, informal, and iterative communications. Business processes are not optimized to make the transfer straightforward. Neither development nor manufacturing systems are designed to support the transition. Information requires bi-directional translation rather than flowing in a smooth fashion. One global pharmaceutical company decided to prioritize this area, go after the problems, implement solutions, and turn deficiencies into a strategic advantage.